How often does ADMA Biologics appear in global news?

Tracked across 1 news events drawn from 301 articles.

What is ADMA Biologics's current news sentiment?

Aggregate sentiment score: -80 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

How prominent is ADMA Biologics in global news coverage?

Attention score of 6, derived from article volume and coverage intensity across 1 events.

What is the most recent event involving ADMA Biologics?

ADMA Biologics Securities Fraud Lawsuits (Apr 01, 2026, 301 articles).

Who is ADMA Biologics most connected to?

Top relationships: Culper Research (target), Culper Research (activist), United States — United States District Court for the District of New Jersey.

How is this data collected?

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.

Company

ADMA Biologics

Tracked across 1 events · 301 articles · First seen Apr 01, 2026 · Last active Jul 05, 2026

Sentiment

-80

Attention

Events

Relationships

Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard

Events (1)

6 -80

Regulatory

ADMA Biologics Securities Fraud Lawsuits

Impact: ADMA Biologics is the primary subject of the class action lawsuits and investigations due to allegations of channel stuffing, undisclosed related-party transactions, and misleading revenue growth, which caused its stock price to decline significantly.

Apr 01, 2026 · 301 articles

Key Actions (18)

100 Lowey Dannenberg investigating ADMA Biologics ADMA Biologics Securities...

100 Glancy Prongay & Murray filed class action lawsuit ADMA Biologics ADMA Biologics Securities...

97 Rosen Law Firm announced investigation ADMA Biologics ADMA Biologics Securities...

97 Bronstein, Gewirtz & Grossman, LLC filed class action lawsuit ADMA Biologics ADMA Biologics Securities...

93 Kahn Swick & Foti notified investors of lawsuit ADMA Biologics ADMA Biologics Securities...

92 Culper Research published report ADMA Biologics ADMA Biologics Securities...

90 ADMA Biologics induced distributor stockADMA Biologics Securities...

90 Bleichmar Fonti & Auld LLP announced investigation ADMA Biologics ADMA Biologics Securities...

90 Faruqi & Faruqi investigating claims against ADMA Biologics ADMA Biologics Securities...

90 Robbins Geller Rudman & Dowd LLP announced class action ADMA Biologics ADMA Biologics Securities...

90 The Schall Law Firm reminded investors of lawsuit ADMA Biologics ADMA Biologics Securities...

90 Kessler Topaz Meltzer & Check filed lawsuit ADMA Biologics ADMA Biologics Securities...

90 Kirby McInerney LLP filed lawsuit ADMA Biologics ADMA Biologics Securities...

88 Pomerantz LLP investigated claims ADMA Biologics ADMA Biologics Securities...

82 ADMA Biologics reported revenue growthADMA Biologics Securities...

81 ADMA Biologics stock declinedADMA Biologics Securities...

76 Cantor Fitzgerald downgraded ADMA Biologics ADMA Biologics Securities...

75 ADMA Biologics withdrew financial guidanceADMA Biologics Securities...

Relationships (6)

Culper Research target ↔ ADMA Biologics ADMA Biologics is the target of an activist short campaign by Culper Research, f

Culper Research activist ↔ ADMA Biologics Culper Research acts as an activist short seller against ADMA Biologics, publish

United States — United States District Court for the District of New Jersey ↔ ADMA Biologics

Cantor Fitzgerald ↔ ADMA Biologics

ERGEN INTELLIGENCE

Track ADMA Biologics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard